Gerd Reifschneider
Euro-Centrum(PL)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Parkinson's Disease Mechanisms and Treatments, Polyomavirus and related diseases, Neurological disorders and treatments, Rheumatoid Arthritis Research and Therapies
Most-Cited Works
- → Long-term safety and efficacy of teriflunomide(2016)126 cited
- → Switching from natalizumab to fingolimod(2015)116 cited
- → Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage(2013)113 cited
- → Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial(2022)106 cited
- → Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial(2020)102 cited
- → Detection of early atherosclerotic lesions by duplex scanning of the carotid artery(1984)90 cited
- → Quality of life in 1000 patients with early relapsing–remitting multiple sclerosis(2009)77 cited
- → Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease(2010)66 cited
- → Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis(2022)64 cited
- → Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom(2010)43 cited